US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Irbesartan Tablets USP

Reason CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Lupin Pharmaceuticals Inc. NDC 68180-411-06 D-0087-2022
Class II · Moderate risk Terminated

Irbesartan Tablets USP

Reason CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Lupin Pharmaceuticals Inc. NDC 68180-410-06 D-0086-2022
Class II · Moderate risk Terminated

Imipramine Pamoate Capsules 125 mg

Reason Out of specification result observed in a dissolution test at the 9-month long term stability time point.

Lupin Pharmaceuticals Inc. NDC 68180-316-06 D-0027-2022
Class II · Moderate risk Terminated

Dr. Reddy's Ezetimibe and Simvastatin Tablets

Reason Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Dr. Reddy's Laboratories, Inc. NDC 43598-743-05 D-0085-2022
Class II · Moderate risk Terminated

Dr. Reddy's Ezetimibe and Simvastatin Tablets

Reason Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity

Dr. Reddy's Laboratories, Inc. NDC 43598-743-30 D-0084-2022
Class II · Moderate risk Terminated

Dr. Reddy's Ezetimibe and Simvastatin Tablets

Reason Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity

Dr. Reddy's Laboratories, Inc. NDC 43598-745-30 D-0083-2022
Class II · Moderate risk Terminated

Dr. Reddy's Ezetimibe and Simvastatin Tablets

Reason Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity

Dr. Reddy's Laboratories, Inc. NDC 43598-744-30 D-0082-2022
Class II · Moderate risk Terminated

Dr. Reddy's Ezetimibe and Simvastatin Tablets

Reason Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity

Dr. Reddy's Laboratories, Inc. NDC 43598-742-90 D-0081-2022
Class II · Moderate risk Terminated

Omeprazole Delayed-Release Capsules

Reason CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.

Dr. Reddy's Laboratories, Inc. NDC 70000-0232-1 D-0026-2022
Class II · Moderate risk Terminated

Betaxolol Ophthalmic Solution

Reason Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.

Akorn, Inc. NDC 17478-705-11 D-0004-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: LOTRIMIN AF (Tolnaftate 1%) manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-2 D-0254-2022
Class II · Moderate risk Terminated

Tinactin

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0777-2 D-0245-2022
Class II · Moderate risk Terminated

Tinactin

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0072-5 D-0244-2022
Class II · Moderate risk Terminated

Tinactin

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0165-3 D-0243-2022
Class II · Moderate risk Terminated

Tinactin

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4162-1 D-0242-2022
Class II · Moderate risk Terminated

Lotrimin AF

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4327-1 D-0241-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-2 D-0240-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-1 D-0239-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0544-2 D-0238-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4140-2 D-0237-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-1272-2 D-0236-2022
Class II · Moderate risk Ongoing

The Natural Dentist Healthy Balance Peppermint Sage

Reason Labeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Menthol with UPC 7 14132 00071 4 instead of Peppermint Oil and Sage Oil with UPC 7 14132 00073 8

Revive Personal Products Company D-0364-2022